Some of the most important issues facing our industry today center on the true role of electronic data capture (EDC). Should it be considered part of electronic health records (EHR)? Who owns the integration of IT data management across clinical trials and patient records in clinical science—and how should the costs be covered?
These were only a few of the questions that arose following a survey conducted by the eClinical Forum last year measuring the global use of EDC in clinical trials—a follow-up to a similar survey conducted in 2001. Of course the world is a bit flatter now than it was then, and the facilitators expected that the data would reflect some significant changes in the industry.
Yet, when the final results were analyzed, what they revealed was still surprising. In particular, despite current pressure on the industry to connect health care and clinical trial systems, and to improve efficiency in care, treatment, and documentation for patients and trial subjects, clinical trials and patient health records still cited an 80% to 100% data input duplication rate.
An expanded view on the topic is available here.
Effect of AI/ML, Real World Evidence and Master Protocols on Trial Success
July 7th 2025How the application of artificial intelligence, broader use of real-world evidence, decentralized clinical trials, master protocols, and risk-based quality monitoring, together with strong ethical oversight and increased collaboration, are contributing to better healthcare delivery and strengthening the role of clinical research in driving global health progress.
Beyond the Molecule: How Human-Centered Design Unlocks AI's Promise in Pharma
June 23rd 2025How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical trials and beyond by aligning intelligent technologies with the people who use them.